文献速递颈动脉与弓上血管

倾向评分匹配比较颈动脉内膜剥脱术与支架置入术的早期结局及再狭窄率

Editor's Choice - Comparison of Early Outcomes and Restenosis Rate Between Carotid Endarterectomy and Carotid Artery Stenting Using Propensity Score Matching Analysis.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2017-10-12

该单中心回顾性研究对2002至2015年1184例颈动脉狭窄患者行倾向评分匹配,形成452对CEA与CAS配对。CAS组30天MACE发生率较高(7.5% vs. 2.4%),但手术相关并发症较低(1.5% vs. 5.3%);平均随访49.1个月,CAS再狭窄率较高(24个月5.4% vs. 1.2%)。结论支持CEA在常规实践中30天MACE和中远期再狭窄率优于CAS。

要点

  • 倾向评分匹配后CAS组30天MACE风险显著高于CEA(7.5% vs. 2.4%)。
  • CEA组手术相关并发症高于CAS(5.3% vs. 1.5%)。
  • 随访24个月CAS再狭窄率高于CEA(5.4% vs. 1.2%)。

核心结论

  • 在常规临床实践中,CEA的30天MACE和中远期再狭窄率低于CAS,与既往随机试验结果一致。

研究设计与样本

  • 单中心回顾性队列研究,纳入2002年1月至2015年12月1184例颈动脉狭窄患者(CEA 654例,CAS 530例),经倾向评分匹配形成452对。
  • 匹配因素包括年龄、性别、高血压、糖尿病、血脂异常、吸烟、房颤、既往PCI或CABG、瓣膜病、对侧颈动脉闭塞、狭窄程度及症状状态。
  • 统计采用逻辑回归分析和log rank检验。

主要发现

  • CAS组30天MACE发生率为7.5%,CEA组为2.4%(OR 3.261,95%CI 1.634-6.509;p = .001)。
  • CAS组手术相关并发症发生率为1.5%,CEA组为5.3%(OR 0.199,95%CI 0.075-0.528;p = .001)。
  • 平均随访49.1个月(范围1-180个月),12个月再狭窄率CAS 1.5% vs. CEA 1.0%,24个月为5.4% vs. 1.2%(p = .008)。

临床怎么用

  • 在与该研究匹配因素相似的无选择颈动脉狭窄患者中,CEA可考虑作为降低30天MACE和中期再狭窄的优先策略。
  • CAS虽手术相关并发症较低,但需权衡其较高的围术期MACE和随访期再狭窄风险。

局限性

  • 单中心回顾性观察性设计,即使采用倾向评分匹配仍可能存在残余混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE/BACKGROUND: Despite randomised evidence, the debate continues about the preferred treatment strategy for carotid stenosis in routine clinical practice. The aim of this study was to compare early outcomes and restenosis rates after carotid endarterectomy (CEA) and carotid stenting (CAS) in unselected patients using propensity score matching (PSM). METHODS: The 30 day incidence of major adverse clinical events (MACE; defined as stroke, transient ischaemic attack, myocardial infarction, or death) and procedure related complications, as well as restenosis rates during follow-up were compared between unselected patients undergoing CEA or CAS between January 2002 and December 2015 at a single institution. PSM was used to balance the following factors between the CEA and CAS cohorts: age, sex, hypertension, diabetes, dyslipidaemia, smoking, atrial fibrillation, previous percutaneous coronary intervention or coronary artery bypass grafting, valvular heart disease, contralateral carotid occlusion, degree of carotid stenosis, and symptomatic status. Statistical comparisons of outcomes were based on logistic regression analysis and log rank test. RESULTS: Of 1184 patients (654 CEA and 530 CAS), 452 PSM pairs of CEA and CAS patients were created. The CAS group showed a relatively higher 30 day incidence of MACE (7.5% vs. 2.4%; odds ratio [OR] 3.261, 95% confidence interval [CI] 1.634-6.509; p = .001) but a lower incidence of procedure related complications (1.5% vs. 5.3%; OR 0.199, 95% CI 0.075-0.528; p = .001). During a mean follow-up of 49.1 months (range 1-180 months), restenosis rates were higher after CAS than after CEA (1.5% vs. 1.0% at 12 months and 5.4% vs. 1.2% at 24 months, respectively; p = .008). CONCLUSION: This PSM based observation reconfirmed previous trial results in both asymptomatic and symptomatic patients with carotid artery stenosis in routine clinical practice: CEA showed lower 30 day MACE and mid-term restenosis rates than CAS.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Heo SH, Yoon KW, Woo SY, et al. Editor's Choice - Comparison of Early Outcomes and Restenosis Rate Between Carotid Endarterectomy and Carotid Artery Stenting Using Propensity Score Matching Analysis. Eur J Vasc Endovasc Surg. 2017. PMID: 28893482. doi:10.1016/j.ejvs.2017.08.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。